Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150940 · ClinicalTrials.gov registry record
Changing the Pulse of Athletics: Applying a Standardized Cardiac Athletic Screening for NCAA Athletes
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 42
- Enrollment target
NCT03150940: Completed study, sponsored by Duke University.
NCT03150940 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150940 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
This is a study supported by Duke Sports Cardiology and Duke Sports Medicine with the intent to enhance the cardiovascular screening of collegiate athletes from a regional to nationally recognized program to understand and eventually reduce cardiovascular events in athletes. The data from this ongoing registry will be used to better understand, refine, and improve the current cardiovascular Duke Athlete Screening process and use this experience as a role model to expand across the ACC.
Primary Outcome
Comparing the false positive rates of use of ultrasound and electrocardiogram
Interventions
- DIAGNOSTIC_TEST ECG
- DIAGNOSTIC_TEST bedside cardiac ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2017-07-30 |
What the finished NCT03150940 record still lists
NCT03150940 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which ECG is the first listed.
NCT03150940 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03150940 about?
NCT03150940 is a clinical study titled "Changing the Pulse of Athletics: Applying a Standardized Cardiac Athletic Screening for NCAA Athletes". This is a study supported by Duke Sports Cardiology and Duke Sports Medicine with the intent to enhance the cardiovascular screening of collegiate athletes from a regional to nationally recognized program to understand and eventually reduce cardiovascular events in athletes. The data from this ongoi...
What is the current status of trial NCT03150940?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2017-05-08. Estimated completion is 2017-07-30.
What interventions are being tested in trial NCT03150940?
The interventions under investigation include: ECG (DIAGNOSTIC_TEST), bedside cardiac ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03150940?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI